Published in J Virol on March 01, 1995
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80
Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J Virol (2003) 2.72
A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J Virol (1999) 2.58
Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J Virol (1995) 1.85
The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J Virol (1996) 1.63
A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J Virol (2001) 1.59
Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis. J Virol (2005) 1.51
Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev (2008) 1.50
The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J Virol (1996) 1.44
Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. Rev Med Virol (2009) 1.31
An acidic cluster of human cytomegalovirus UL99 tegument protein is required for trafficking and function. J Virol (2004) 1.24
Viral and host control of cytomegalovirus maturation. Trends Microbiol (2012) 1.15
Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts. Virol J (2006) 1.13
The human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication. J Virol (2011) 1.12
Translational regulation of the human cytomegalovirus pp28 (UL99) late gene. J Virol (1997) 1.10
The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis. J Virol (2007) 1.10
Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J Virol (2011) 1.05
Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription. J Virol (2009) 1.03
The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein. J Virol (1995) 1.02
Identification of human cytomegalovirus genes important for biogenesis of the cytoplasmic virion assembly complex. J Virol (2014) 0.93
The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection. J Virol (1997) 0.92
Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses. J Virol (2013) 0.92
Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes. J Virol (2013) 0.91
Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility. J Virol (2014) 0.87
The human cytomegalovirus UL76 gene regulates the level of expression of the UL77 gene. PLoS One (2010) 0.81
Human cytomegalovirus transcriptome activity differs during replication in human fibroblast, epithelial and astrocyte cell lines. J Gen Virol (2012) 0.79
Functional annotation of human cytomegalovirus gene products: an update. Front Microbiol (2014) 0.79
Structural modelling and mutagenesis of human cytomegalovirus alkaline nuclease UL98. J Gen Virol (2011) 0.79
Human Cytomegalovirus pUL93 Links Nucleocapsid Maturation and Nuclear Egress. J Virol (2016) 0.75
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res (1984) 39.52
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev (1994) 8.92
Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection. J Virol (1982) 6.20
Organization and expression of the immediate early genes of human cytomegalovirus. J Virol (1983) 5.74
Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J Virol (1985) 5.09
Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter. J Virol (1987) 4.33
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
Temporal regulation of human cytomegalovirus transcription at immediate early and early times after infection. J Virol (1981) 4.11
Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol Cell Biol (1989) 4.10
Human cytomegalovirus. III. Virus-induced DNA polymerase. J Virol (1975) 4.06
Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J (1986) 3.89
A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (1992) 3.59
Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J Virol (1993) 3.53
Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol (1992) 3.41
A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol Cell Biol (1993) 3.38
Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene. J Virol (1987) 3.36
E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell (1994) 3.24
Stimulation of cellular thymidine kinases by human cytomegalovirus. J Virol (1977) 3.17
The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture. J Virol (1991) 3.13
Patterns of transcription of human cytomegalovirus in permissively infected cells. J Virol (1980) 3.08
Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J Gen Virol (1989) 3.01
Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature (1992) 2.98
The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22. Proc Natl Acad Sci U S A (1992) 2.97
Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J Virol (1992) 2.95
Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. J Virol (1988) 2.90
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev (1989) 2.82
Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J Virol (1992) 2.72
A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection. J Virol (1989) 2.70
Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature (1988) 2.68
Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. J Virol (1989) 2.68
Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. J Virol (1987) 2.60
An enhancer element in the short unique region of human cytomegalovirus regulates the production of a group of abundant immediate early transcripts. Virology (1988) 2.46
Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol (1988) 2.35
The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol (1989) 2.32
Analysis of the major transcripts encoded by the long repeat of human cytomegalovirus strain AD169. J Virol (1985) 2.15
Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. J Virol (1987) 2.11
High-resolution characterization of herpes simplex virus type 1 transcripts encoding alkaline exonuclease and a 50,000-dalton protein tentatively identified as a capsid protein. J Virol (1983) 2.07
Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J Gen Virol (1990) 2.06
Functional analysis of GC element binding and transcription in the hamster dihydrofolate reductase gene promoter. Nucleic Acids Res (1989) 2.03
E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol Cell Biol (1992) 2.01
Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus. J Virol (1988) 2.00
Characterization of the genes encoding herpes simplex virus type 1 and type 2 alkaline exonucleases and overlapping proteins. J Virol (1986) 1.92
2.2-kilobase class of early transcripts encoded by cell-related sequences in human cytomegalovirus strain AD169. J Virol (1986) 1.91
Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol Cell Biol (1990) 1.90
The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J Gen Virol (1992) 1.84
Expression of the human cytomegalovirus UL36-38 immediate early region during permissive infection. Virology (1991) 1.83
Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol (1989) 1.83
Cytomegalovirus assembly protein nested gene family: four 3'-coterminal transcripts encode four in-frame, overlapping proteins. J Virol (1991) 1.82
Expression of a human cytomegalovirus late gene is posttranscriptionally regulated by a 3'-end-processing event occurring exclusively late after infection. Mol Cell Biol (1986) 1.78
Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses. J Virol (1989) 1.78
Cell-activation responses to cytomegalovirus infection relationship to the phasing of CMV replication and to the induction of cellular damage. Subcell Biochem (1989) 1.68
Sequences in the human cytomegalovirus 2.7-kilobase RNA promoter which mediate its regulation as an early gene. J Virol (1989) 1.57
Mapping and expression of a human cytomegalovirus major viral protein. J Virol (1984) 1.55
Herpesviruses encode an unusual protein-serine/threonine kinase which is nonessential for growth in cultured cells. J Virol (1992) 1.53
Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product. J Virol (1992) 1.46
Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit. J Virol (1989) 1.45
Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed. J Virol (1991) 1.43
The cDNA of UL15, a highly conserved herpes simplex virus 1 gene, effectively replaces the two exons of the wild-type virus. J Virol (1992) 1.43
The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate early enhancer. J Gen Virol (1989) 1.39
Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation. J Virol (1992) 1.31
An AP-1 binding site is the predominant cis-acting regulatory element in the 1.2-kilobase early RNA promoter of human cytomegalovirus. J Virol (1992) 1.24
The human cytomegalovirus 2.7-kilobase RNA promoter contains a functional binding site for the adenovirus major late transcription factor. J Virol (1990) 1.24
Stimulation of ornithine decarboxylase by human cytomegalovirus. J Gen Virol (1979) 1.19
Molecular cloning and analysis of three cDNA clones homologous to human cytomegalovirus RNAs present during late infection. J Virol (1986) 1.08
Human cytomegalovirus induces expression of cellular topoisomerase II. J Virol (1990) 1.06
Analysis of a region of the human cytomegalovirus (AD169) genome coding for a 25-kilodalton virion protein. J Virol (1989) 1.04
Characterization of a human cytomegalovirus 1.6-kilobase late mRNA and identification of its putative protein product. J Virol (1991) 1.00
A possible role for nonsense suppression in the synthesis of a human cytomegalovirus 58-kDa virion protein. Virology (1992) 0.94
Cloning and characterization of cDNA clones corresponding to transcripts from the BamHI G region of the Epstein-Barr virus genome and expression of BGLF2. J Gen Virol (1991) 0.91
Pathogenesis of CMV-associated diseases in 1990. Transplant Proc (1991) 0.87
The HCMV genome project: what has been learned and what can be expected in the future. Transplant Proc (1991) 0.84
Genomic localization of the gene encoding a 32-kDa capsid protein of human cytomegalovirus. Virology (1988) 0.81
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Structural polypeptides of simian virus 40. J Virol (1971) 4.83
Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol (1973) 4.43
Human cytomegalovirus. III. Virus-induced DNA polymerase. J Virol (1975) 4.06
Analysis of simian virus 40 DNA with the restriction enzyme of Haemophilus aegyptius, endonuclease Z. J Virol (1973) 3.98
Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 3.82
Stimulation of cellular thymidine kinases by human cytomegalovirus. J Virol (1977) 3.17
Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid. J Virol (1975) 2.64
Human cytomegalovirus genome: partial denaturation map and organization of genome sequences. J Virol (1977) 2.63
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Detection of human cytomegalovirus and analysis of strain variation. Yale J Biol Med (1976) 2.53
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol (1997) 2.24
Structure and function of the polypeptides in simian virus 40. I. Existence of subviral deoxynucleoprotein complexes. J Virol (1972) 2.16
Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol (1995) 2.16
Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother (1983) 2.09
Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol (2001) 2.07
Ab initio construction of protein tertiary structures using a hierarchical approach. J Mol Biol (2000) 2.05
E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol Cell Biol (1992) 2.01
Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3). Mol Cell Biol (1993) 2.00
Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus. J Virol (1974) 1.99
Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer (1980) 1.90
Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol (1976) 1.87
Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A (1993) 1.84
Factors affecting the ability of energy functions to discriminate correct from incorrect folds. J Mol Biol (1997) 1.84
Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J Immunol (1999) 1.79
Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. J Virol (1997) 1.78
Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J Virol (1993) 1.73
Cytotoxicity of sesquiterpene lactones. Cancer Res (1971) 1.71
Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology (1992) 1.64
The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J Virol (1996) 1.63
Nucleotide sequence of a human cytomegalovirus DNA fragment encoding a 67-kilodalton phosphorylated viral protein. J Virol (1985) 1.62
Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet (1982) 1.59
Cytomegalovirus: genetic variation of viral genomes. Ann N Y Acad Sci (1980) 1.59
Mapping and expression of a human cytomegalovirus major viral protein. J Virol (1984) 1.55
Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin. J Virol (1975) 1.48
Autologous human B and T lymphoblastoid cell lines. Nature (1974) 1.48
Structure and function of the polypeptides in simian virus 40. II. Transcription of subviral deoxynucleoprotein complexes in vitro. J Virol (1972) 1.47
Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product. J Virol (1992) 1.46
Molecular epidemiology of cytomegalovirus infections in women and their infants. N Engl J Med (1980) 1.46
The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J Virol (1996) 1.44
Epstein-Barr virus-associated thymidine kinase. J Virol (1978) 1.38
Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res (2000) 1.37
The role of MKK1/2 kinase activity in human cytomegalovirus infection. J Gen Virol (2001) 1.35
Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J Virol (2000) 1.33
Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells. Biotechnol Appl Biochem (1988) 1.32
Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J Biol Chem (1988) 1.32
Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests. J Immunol (1974) 1.31
Cytomegalovirus D.N.A. and adenocarcinoma of the colon: Evidence for latent viral infection. Lancet (1978) 1.31
Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies. Int J Cancer (1981) 1.26
Are predicted structures good enough to preserve functional sites? Structure (1999) 1.26
Human cytomegalovirus-associated DNA polymerase and protein kinase activities. J Gen Virol (1981) 1.23
Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. J Immunol (1989) 1.22
Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J Med Virol (1988) 1.21
Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res (1998) 1.21
Purification and characterization of varicella-zoster virus-induced DNA polymerase. J Virol (1978) 1.17
Effect of 9-(2-hydroxyethoxymethyl)guanine on viral-specific polypeptide synthesis in human cytomegalovirus-infected cells. Am J Med (1982) 1.17
The role of turns in the structure of an alpha-helical protein. Nature (1993) 1.17
Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochem Pharmacol (1996) 1.16
Effects of certain nucleoside analogues on human cytomegalovirus replication in vitro. J Gen Virol (1984) 1.15
Cytomegalovirus vaccine virus (Towne strain) does not induce latency. J Infect Dis (1985) 1.11
A combined approach for ab initio construction of low resolution protein tertiary structures from sequence. Pac Symp Biocomput (1999) 1.11
Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR. Virology (1989) 1.11
Restriction endonuclease analysis of cytomegalovirus deoxyribonucleic acid as an epidemiologic tool. Pediatrics (1982) 1.10
Constructing side chains on near-native main chains for ab initio protein structure prediction. Protein Eng (2000) 1.09
Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. Ann Intern Med (1985) 1.06
Human cytomegalovirus induces expression of cellular topoisomerase II. J Virol (1990) 1.06
Cytomegalovirus: detection in human colonic and circulating mononuclear cells in association with gastrointestinal disease. Int J Cancer (1981) 1.02
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. Ann Intern Med (1979) 1.01
Persistence of CMV genome in lymphoid cells after congenital infection. Nature (1975) 1.01
High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients. J Infect Dis (1993) 0.99
Iodination of herpesvirus nucleic acids. J Virol (1975) 0.97
Preferential inhibition of herpes-group viruses by phosphonoacetic acid: effect on virus DNA synthesis and virus-induced DNA polymerase activity. Yale J Biol Med (1976) 0.97
Characterization of a structurally tricistronic gene of human cytomegalovirus composed of U(s)18, U(s)19, and U(s)20. J Virol (1993) 0.97
Domain mapping of the human cytomegalovirus IE1-72 and cellular p107 protein-protein interaction and the possible functional consequences. J Gen Virol (1999) 0.97
Synthesis of sex steroids by cellular components of chicken follicles. Biol Reprod (1979) 0.97
Genetic analysis of a cytomegalovirus-like agent isolated from human brain. J Virol (1978) 0.96
Chromatin pattern consisting of repeating bipartite structures in WI-38 cells infected with human cytomegalovirus. J Virol (1978) 0.94
In vitro expression of the human cytomegalovirus DNA polymerase gene: effects of sequence alterations on enzyme activity. J Virol (1993) 0.93
Simultaneous congenital infection with Epstein-Barr virus and cytomegalovirus. N Engl J Med (1981) 0.93
Interaction of human cytomegalovirus with p53: possible role in coronary restenosis. Scand J Infect Dis Suppl (1995) 0.92
Murine cytomegalovirus-induced congenital defects and fetal maldevelopment. J Infect Dis (1983) 0.92
Cervical cytomegalovirus infection in prostitutes and in women attending a sexually transmitted disease clinic. J Med Virol (1994) 0.92
Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome. J Virol (1988) 0.91
Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells. J Biol Chem (1999) 0.91
Estrogenic and antiestrogenic effects of enclomiphene and zuclomiphene on gonadotropin secretion by ovine pituitary cells in culture. Endocrinology (1983) 0.90
Cytomegalovirus excretion in pregnant and nonpregnant women. J Clin Microbiol (1993) 0.90
Demonstration of developmental anomalies in mouse fetuses by transfer of murine cytomegalovirus DNA-injected eggs to surrogate mothers. J Infect Dis (1993) 0.89
Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H - imidazole on HCMV DNA replication and permissive infection. Antiviral Res (1999) 0.88
Cytomegalovirus infection and viral shedding in the genital tract of infertile couples. J Med Virol (1995) 0.88
Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts. Mol Biol Cell (1992) 0.87
The effect of 1,25-dihydroxyvitamin D3 treatment on calcitonin and calcitonin gene-related peptide mRNA levels in cultured human thyroid C-cells. Biochem Biophys Res Commun (1987) 0.86
Antitumor agents. 207. Design, synthesis, and biological testing of 4beta-anilino-2-fluoro-4'-demethylpodophyllotoxin analogues as cytotoxic and antiviral agents. J Med Chem (2001) 0.86
Productive infection of human endometrial stromal cells by human cytomegalovirus. Virology (1994) 0.86
Replication of cytomegalovirus DNA in human lymphoblastoid cells. IARC Sci Publ (1975) 0.85
Glioblastoma cell-specific expression of fibroblast growth factor receptor-1beta requires an intronic repressor of RNA splicing. Cancer Res (1999) 0.85
Urinary cytomegalovirus shedding profile in children with subclinical infection. Lancet (1993) 0.84